Article
The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2…
medRxiv · 2020 · Kim M. Stegmann
Key facts
| Title | The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models |
|---|---|
| First author | Kim M. Stegmann |
| Journal | medRxiv |
| Published | Aug 15, 2020 |
| DOI | 10.1101/2020.07.18.210013 |
| Devices mentioned | K060774, K073490, K113793 |
| Product codes mentioned | CFN, CGN, LPS, PEG, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1